Justine C. Migdall-Wilson, Ph.D.
Affiliations: | 2012 | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Area:
Molecular BiologyGoogle:
"Justine Migdall-Wilson"Parents
Sign in to add mentor| Douglas K. Graham | grad student | 2012 | University of Colorado, Denver | |
| (Novel oncogenic roles of Mer receptor tyrosine kinase in acute lymphoblastic leukemia.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Brandao LN, Winges A, Christoph S, et al. (2013) Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia. Blood Cancer Journal. 3: e101 |
| Linger RM, Cohen RA, Cummings CT, et al. (2013) Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer. Oncogene. 32: 3420-31 |
| Migdall-Wilson J, Bates C, Schlegel J, et al. (2012) Prolonged exposure to a Mer ligand in leukemia: Gas6 favors expression of a partial Mer glycoform and reveals a novel role for Mer in the nucleus. Plos One. 7: e31635 |
| Brandão L, Migdall-Wilson J, Eisenman K, et al. (2011) TAM receptors in leukemia: expression, signaling, and therapeutic implications. Critical Reviews in Oncogenesis. 16: 47-63 |